Literature DB >> 28050046

Reply to Matushita et al.

S Sahami1,2, C J Buskens1, G R van den Brink2, G R D'haens2, W A Bemelman1.   

Abstract

Year:  2017        PMID： 28050046     DOI： 10.1038/ajg.2016.487

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Possible link between ulcerative colitis and in situ adenocarcinoma of an appendiceal mucocele: importance of inflammation in the appendiceal orifice related to UC.

Authors:  Yasuhiro Takeda; Hiroshi Nakase; Sakae Mikami; Tateaki Inoue; Seizi Satou; Yoshiharu Sakai; Tsutomu Chiba
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

2.  European evidence based consensus for endoscopy in inflammatory bowel disease.

Authors:  Vito Annese; Marco Daperno; Matthew D Rutter; Aurelien Amiot; Peter Bossuyt; James East; Marc Ferrante; Martin Götz; Konstantinos H Katsanos; Ralf Kießlich; Ingrid Ordás; Alessandro Repici; Bruno Rosa; Shaji Sebastian; Torsten Kucharzik; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2013-11-01       Impact factor: 9.071

3.  Significant association of appendiceal neoplasms and ulcerative colitis rather than Crohn's disease.

Authors:  Mitsunobu Matsushita; Toshihiro Tanaka; Mika Omiya; Kazuichi Okazaki
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 5.  Intestinal inflammation and cancer.

Authors:  Thomas A Ullman; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 6.  The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms.

Authors:  S Sahami; I A Kooij; S L Meijer; G R Van den Brink; C J Buskens; A A Te Velde
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.